Crystal Structure and Site 1 Binding Energetics of Human Placental Lactogen

Journal of Molecular Biology

Volumn 358, Issue 3, 2006, Pages 773-784

  Walsh, Scott T R ^a,b   Kossiakoff, Anthony A ^b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

alanine scanning; human placental lactogen; human prolactin receptor; surface plasmon resonance; X ray crystallography

Indexed keywords

CYTOKINE; EPITOPE; HUMAN PLACENTA LACTOGEN; ZINC;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CRYSTAL STRUCTURE; ENERGY TRANSFER; HUMAN; KINETICS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURFACE PLASMON RESONANCE;

ANIMALIA; PRIMATES;

EID: 33646065935     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.02.038     Document Type: Article

References (48)

1. Goffin V., and Kelly P.A. The prolactin/growth hormone receptor family: structure/function relationships. J. Mammary Gland Biol. Neoplasia 2 (1997) 7-17
2. Genuth S.M. In: Berne R.M., and Levy M.N. (Eds). The Endocrine System. Physiology. 2nd edit. (1988), C.V. Mosby Company, St. Louis, MI
3. Fuh G., Colosi P., Wood W.I., and Wells J.A. Rational design of potent antagonists to the human growth hormone receptor. Science 268 (1992) 5376-5381
4. Fuh G., and Wells J.A. Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270 (1995) 13133-13137
5. Cunningham B.C., Bass S., Fuh G., and Wells J.A. Zinc mediation of the binding of humane growth hormone to the human prolactin receptor. Science 250 (1990) 1709-1712
6. Lowman H.B., Cunningham B.C., and Wells J.A. Mutational analysis and protein engineering of receptor-binding determinants in human placental lactogen. J. Biol. Chem. 266 (1991) 10982-10988
7. Goffin V., Binart N., Touraine P., and Kelly P.A. Prolactin: the new biology of an old hormone. Annu. Rev. Physiol. 64 (2002) 47-67
8. Wells J.A. Binding in the growth hormone receptor complex. Proc. Natl Acad. Sci. USA 93 (1996) 1-6
9. Kossiakoff A.A., and de Vos A.M. Structural basis for cytokine hormone-receptor recognition and receptor activation. Advan. Protein Chem. 52 (1998) 67-108
10. Kossiakoff A.A. The structural basis for biological signaling, regulation, and specificity in the growth hormone-prolactin system of hormones and receptors. Advan. Protein Chem. 68 (2004) 147-169
11. Herman A., Helman D., Livnah O., and Gertler A. Ruminant placental lactogens act as antagonists to homologous growth hormone receptors and as agonists to human or rabbit growth hormone receptors. J. Biol. Chem. 274 (1999) 7631-7639
12. Herman A., Bignon C., Daniel N., Gosclaude J., Gertler A., and Dijane J. Functional heterodimerization of prolactin and growth hormone receptors by ovine placental lactogen. J. Biol. Chem. 275 (2000) 6295-6301
13. Elkins P.A., Christinger H.W., Sandowski Y., Sakal E., Gertler A., de Vos A.M., and Kossiakoff A.A. Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor. Nature Struct. Biol. 7 (2000) 808-815
14. Somers W., Ultsch M., de Vos A.M., and Kossiakoff A.A. The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372 (1994) 478-481
15. Hendrickson W.A. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science 254 (1991) 51-58
16. de Vos A.M., Ultsch M., and Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255 (1992) 306-312
17. Teilum K., Hoch J.C., Goffin V., Kinet S., Martial J.A., and Kragelund B.B. Solution structure of human prolactin. J. Mol. Biol. 351 (2005) 810-823
18. Abdel-Meguid S.S., Shieh H.S., Smith W.W., Dayringer H.E., Violand B.N., and Bentle L.A. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl Acad. Sci. USA 84 (1987) 6434-6437
19. Clackson T., Ultsch M.H., Wells J.A., and de Vos A.M. Structural and functional analysis of the 1:1 growth hormone:receptor complex reveals the molecular basis for receptor affinity. J. Mol. Biol. 277 (1998) 1111-1128
20. Kasimova M.R., Kristensen S.M., Howe P.W., Christensen T., Matthiesen F., Petersen J., et al. NMR studies of the backbone flexibility and structure of human growth hormone: a comparison of high and low pH conformations. J. Mol. Biol. 318 (2002) 679-695
21. Kossiakoff A.A., Somers W., Ultsch M., Andow K., Muller Y.A., and de Vos A.M. Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 3 (1994) 1697-1705
22. Walsh S.T., Jevitts L.M., Sylvester J.E., and Kossiakoff A.A. Site2 binding energetics of the regulatory step of growth hormone-induced receptor homodimerization. Protein Sci. 12 (2003) 1960-1970
23. Cunningham B.C., and Wells J.A. Rational design of receptor-specific variants of human growth hormone. Proc. Natl Acad. Sci. USA 88 (1991) 3407-3411
24. Sivaprasad U., Canfield J.M., and Brooks C.L. Mechanism for ordered receptor binding by human prolactin. Biochemistry 43 (2004) 13755-13765
25. Bernat B., Sun M., Dwyer M., Feldkamp M., and Kossiakoff A.A. Dissecting the binding energy epitope of a high-affinity variant of human growth hormone: cooperative and additive effects from combining mutations from independently selected phage display mutagenesis libraries. Biochemistry 43 (2004) 6076-6084
26. Cunningham B.C., and Wells J.A. Comparison of a structural and a functional epitope. J. Mol. Biol. 234 (1993) 554-563
27. Bernat B., Pal G., Sun M., and Kossiakoff A.A. Determination of the energetics governing the regulatory step in growth hormone-induced receptor homodimerization. Proc. Natl Acad. Sci. USA 100 (2003) 952-957
28. Walsh S.T., Sylvester J.E., and Kossiakoff A.A. The high- and low-affinity receptor binding sites of growth hormone are allosterically coupled. Proc. Natl Acad. Sci. USA 101 (2004) 17078-17083
29. Kouadio J.L., Horn J.R., Pal G., and Kossiakoff A.A. Shotgun alanine scanning shows that growth hormone can bind productively to its receptor through a drastically minimized interface. J. Biol. Chem. 280 (2005) 25524-25532
30. Liparoto S.F., and Ciardelli T.L. Biosensor analysis of the interleukin-2 receptor complex. J. Mol. Recogn. 12 (1999) 316-321
31. Shen B.J., Hage T., and Sebald W. Global and local determinants for the kinetics of interleukin-4/interleukin-4 receptor alpha chain interaction. A biosensor study employing recombinant interleukin-4-binding protein. Eur. J. Biochem. 240 (1996) 252-261
32. Wang Y., Shen B.J., and Sebald W. A mixed-charge pair in human interleukin 4 dominates high-affinity interaction with the receptor alpha chain. Proc. Natl Acad. Sci. USA 94 (1997) 1657-1662
33. Hensley P., Doyle M.L., Myszka D.G., Woody R.W., Brigham-Burke M.R., Erickson-Miller C.L., et al. Evaluating energetics of erythropoietin ligand binding to homodimerized receptor extracellular domains. Methods Enzymol. 323 (2000) 177-207
34. Nice E., Layton J., Fabri L., Hellman U., Engstrom A., Persson B., and Burgess A.W. Mapping of the antibody- and receptor-binding domains of granulocyte colony-stimulating factor using an optical biosensor. Comparison with enzyme-linked immunosorbent assay competition studies. J. Chromatog. 646 (1993) 159-168
35. Schiffer C., Ultsch M., Walsh S., Somers W., de Vos A.M., and Kossiakoff A. Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites. J. Mol. Biol. 316 (2002) 277-289
36. Fuh G., Mulkerrin M.G., Bass S., McFarland N., Brochier M., Bourell J.H., et al. The human growth hormone receptor. J. Biol. Chem. 265 (1990) 3111-3115
37. Kunkel T.A., Roberts J.D., and Zakour R.A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154 (1987) 367-382
38. Chang C.N., Rey M., Bochner B., Heyneker H., and Gray G. High-level secretion of human growth hormone by Escherichia coli. Gene 55 (1987) 189-196
39. Otiwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter C.W.J., and Sweet R.M. (Eds). Methods in Enzymology vol. 276 (1997), Academic Press, New York 307-326
40. Terwilliger T.C. SOLVE and RESOLVE: automated structure solution and density modification. Methods Enzymol. 374 (2003) 22-37
41. Brunger A.T. Assessment of phase accuracy by cross validation: the free R value. Methods and applications. Acta Crystallog. sect. D 49 (1993) 24-36
42. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
43. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D 54 (1998) 905-921
44. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
45. Collaborative Computing Project Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
46. Laskowski R., MacArthur M., Moss D., and Thornton J. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26 (1993) 283-291
47. Myszka D.G., and Morton T.A. Clamp: a biosensor kinetic data analysis program. Trends Biochem. Sci. 23 (1998) 149-150
48. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22 (1994) 4673-4680